What comparative genomics taught us about the vaginal commensal Lactobacillus crispatus

This story started during a conference in Athens in 2014 when I talked about a novel concept for personalised therapy with probiotics isolated from the host. I have to admit that I was somewhat disappointed by the lack of response from the audience to what I in all modesty took for the-most-revolutionary-idea-which-without-doubt-would-open-up-a-whole-new-field-of bacteriotherapy. So, what was this all about?
Published in Microbiology
What comparative genomics taught us about the vaginal commensal Lactobacillus crispatus
Like

Read the paper

BioMed Central
BioMed Central BioMed Central

Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota - Microbiome

Background A vaginal microbiota dominated by lactobacilli (particularly Lactobacillus crispatus) is associated with vaginal health, whereas a vaginal microbiota not dominated by lactobacilli is considered dysbiotic. Here we investigated whether L. crispatus strains isolated from the vaginal tract of women with Lactobacillus-dominated vaginal microbiota (LVM) are pheno- or genotypically distinct from L. crispatus strains isolated from vaginal samples with dysbiotic vaginal microbiota (DVM). Results We studied 33 L. crispatus strains (n = 16 from LVM; n = 17 from DVM). Comparison of these two groups of strains showed that, although strain differences existed, both groups degraded various carbohydrates, produced similar amounts of organic acids, inhibited Neisseria gonorrhoeae growth, and did not produce biofilms. Comparative genomics analyses of 28 strains (n = 12 LVM; n = 16 DVM) revealed a novel, 3-fragmented glycosyltransferase gene that was more prevalent among strains isolated from DVM. Most L. crispatus strains showed growth on glycogen-supplemented growth media. Strains that showed less-efficient (n = 6) or no (n = 1) growth on glycogen all carried N-terminal deletions (respectively, 29 and 37 amino acid deletions) in a putative pullulanase type I protein. Discussion L. crispatus strains isolated from LVM were not phenotypically distinct from L. crispatus strains isolated from DVM; however, the finding that the latter were more likely to carry a 3-fragmented glycosyltransferase gene may indicate a role for cell surface glycoconjugates, which may shape vaginal microbiota-host interactions. Furthermore, the observation that variation in the pullulanase type I gene is associated with growth on glycogen discourages previous claims that L. crispatus cannot directly utilize glycogen.

Well, by the use of cultivation techniques, my research team was able to demonstrate the transition from a dysbiotic vaginal microbiota (DVM) obtained from a vaginal swab to a ‘healthy’ bacterial community dominated by lactobacilli (LVM). A dysbiotic vaginal microbiota, also known as  bacterial vaginosis (BV), is a highly diverse bacterial population depleted from Lactobacillus. Bacterial vaginosis is associated with an increased risk for sexually transmitted diseases including HIV, decreased fertility rates, and adverse pregnancy outcomes. All we need to do next is to disperse the obtained population of vaginal bacteria – note this well -  the woman’s own bacteria into a vaginal gel and use this for a personalised BV-treatment.

 Too good to  be true? The first cracks appeared when I was drinking a cocktail on the roof garden after my talk at the conference reception and an expert in the field approached me. ‘Very nice story’, he said, ‘but your idea will never work’. I swirled the content of my glass as if the sound generated by the ice blocks in my cocktail would act as some kind of spell to blow away his last words. He continued ‘The lactobacilli you are cultivating from the host have lost the ability to dominate the microbial population. The problem is in their genes. Their population will never sustain in vivo’. I took another sip of my Martini on the rocks and assured the expert that I was definitely going to look into this. And so we did. In the laboratory, we selected Lactobacillus crispatus strains from a dysbiotic vaginal microbiota (DVM) and Lactobacillus dominated microbiota (LVM) and systematically checked for differences in the two groups of strains by comparative genomics.

What appeared to be the case? To our big surprise this was not about LVM-strains losing a genetic property, it was  about the DVM-strains gaining one. We found a novel glycosyltransferase gene that was more prevalent among strains isolated from DVM. All speculation at this point, nonetheless this could indicate that, as the vaginal niche in a dysbiotic state is under immune pressure, this gene mediates variation in cell surface glycoconjugates. In other words, this gene encodes for the ability of Lactobacillus crispatus to change its coat making the bacterium invisible to the immune system. A selective advantage for survival under these conditions. Thus, if this appears to be true, the expert is half right. Simple enrichment by cultivation in the lab will not work. We will need to deliberately select for L. crispatus strains containing the glycosyltransferase gene allowing the transition from an inflammatory state of bacterial vaginosis to a Lactobacillus-dominated state. This new insight resulted from a clever comment by an expert at a conference five years ago and the fantastic effort of the researchers who took part in this investigation. Our research appeared in the open access journal Microbiome earlier this week. 

 Reference 

Kort R. Personalized therapy with probiotics from the host by TripleA. Trends Biotechnol. 2014 Jun;32(6):291-3. doi: 10.1016/j.tibtech.2014.04.002.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Francisco Rodriguez-Valera
almost 5 years ago

The glycosyltransferase could also change phage sensitivity

Go to the profile of Remco Kort
almost 5 years ago

Yes, excellent idea. Could be very interesting to have a look  the role of bacteriophages in a student project - would be willing to share the strains (and source of bacteriophages).

Subscribe to the Topic

Microbiology
Life Sciences > Biological Sciences > Microbiology
  • Microbiome Microbiome

    This journal hopes to integrate researchers with common scientific objectives across a broad cross-section of sub-disciplines within microbial ecology. It covers studies of microbiomes colonizing humans, animals, plants or the environment, both built and natural or manipulated, as in agriculture.

Related Collections

With collections, you can get published faster and increase your visibility.

Retroviruses & the Microbiome

The focus of this issue is to move beyond associations to mechanisms and functional interactions, including both replication-competent and endogenous retroviruses, human and non-human hosts, and implications for homeostasis, disease and/or therapeutics.

Publishing Model: Open Access

Deadline: Ongoing

Focus on Microbiome and Cancer

Microbiome is considering submissions looking at the relationship between the microbiome and cancers in this new collection 'Focus on Microbiome and Cancer.

Publishing Model: Open Access

Deadline: Ongoing